HAE FY 2013 Earnings Report — Haemonetics Corporation Revenue & Financial Results | Market Cap Arena

Haemonetics CorporationHAE

FY 2013 Earnings

Reported May 20, 2013

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2013	Prior Q	FY 2012	QoQ Change	YoY Change
Revenue	$892M	—	—	—	—
Op. Income	$56M	—	—	—	—
Gross Margin	48.0%	—	—	—	—
Net Margin	4.3%	—	—	—	—
EPS (Diluted)	$0.74	—	—	—	—
Free Cash Flow	$23M	—	—	—	—

Revenue Flow

Item	Amount
REVENUE	$892M
Cost of Revenue	$464M
GROSS PROFIT	$428M
R&D Expenses	$49M
Selling & Marketing	$5M
General & Administrative	$314M
SG&A Expenses	$319M
Other Expenses	$0
Operating Expenses	$367M
Cost & Expenses	$831M
OPERATING INCOME	$56M
Interest Income	$0
Interest Expense	$7M
Other Income/Expenses	-$7M
INCOME BEFORE TAX	$50M
Income Tax Expense	$11M
Net Income from Continuing Ops	$39M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$39M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$39M
D&A	$65M
EBIT	$61M
EBITDA	$125M
EPS	$1
EPS Diluted	$1

Income Statement

Item	Amount
REVENUE	$892M
Cost of Revenue	$464M
GROSS PROFIT	$428M
R&D Expenses	$49M
Selling & Marketing	$5M
General & Administrative	$314M
SG&A Expenses	$319M
Other Expenses	$0
Operating Expenses	$367M
Cost & Expenses	$831M
OPERATING INCOME	$56M
Interest Income	$0
Interest Expense	$7M
Other Income/Expenses	-$7M
INCOME BEFORE TAX	$50M
Income Tax Expense	$11M
Net Income from Continuing Ops	$39M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$39M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$39M
D&A	$65M
EBIT	$61M
EBITDA	$125M
EPS	$1
EPS Diluted	$1

Cash Flow Statement

Item	Amount
Net Income	$39M
Depreciation & Amortization	$65M
Stock-Based Compensation	$11M
Deferred Income Tax	$589.0K
Other Non-Cash Items	$11M
Change in Working Capital	-$41M
OPERATING CASH FLOW	$85M
Capital Expenditure	-$62M
Acquisitions (Net)	-$535M
Purchases of Investments	-$1M
Sales/Maturities of Investments	$0
Other Investing Activities	-$60M
NET CASH FROM INVESTING	-$596M
Net Debt Issuance	$482M
Common Stock Repurchased	-$50M
Common Dividends Paid	$0
Other Financing Activities	$30M
NET CASH FROM FINANCING	$462M
FREE CASH FLOW	$23M
Net Change in Cash	-$50M

Balance Sheet

Item	Amount
Cash & Equivalents	$179M
Short-Term Investments	$0
Net Receivables	$170M
Inventory	$184M
Other Current Assets	$64M
TOTAL CURRENT ASSETS	$597M
PP&E (Net)	$257M
Goodwill	$330M
Intangible Assets	$264M
Long-Term Investments	-$597M
Tax Assets	$2M
Other Non-Current Assets	$608M
TOTAL NON-CURRENT ASSETS	$865M
TOTAL ASSETS	$1.5B
Account Payables	$50M
Short-Term Debt	$23M
Deferred Revenue	$24M
Other Current Liabilities	$34M
TOTAL CURRENT LIABILITIES	$180M
Long-Term Debt	$457M
Deferred Revenue NC	-$30M
Deferred Tax Liabilities	$30M
Other Non-Current Liabilities	$26M
TOTAL NON-CURRENT LIABILITIES	$513M
TOTAL LIABILITIES	$693M
Common Stock	$510.0K
Additional Paid-In Capital	$365M
Retained Earnings	$398M
Treasury Stock	$0
Accum. Other Comp. Income	$5M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$769M
Minority Interest	$0
TOTAL EQUITY	$769M
TOTAL LIABILITIES & EQUITY	$1.5B
Total Debt	$480M
Net Debt	$301M